TUSTIN, Calif.--(BUSINESS WIRE)--Integrium, a leading contract research organization (CRO) in the cardiovascular and metabolic areas, today announced that the company was awarded workscopes for two large hypertension studies by a major pharmaceutical company. This follows a number of trial workscopes previously managed by Integrium for this client.
